Biomea Fusion
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $56M
Investors
- 9
About Biomea Fusion
Founded in 2017 and headquartered in Redwood City, US, Biomea Fusion, Inc. specializes in developing therapies for chronic metabolic diseases.00 mn on March 2023.Biomea Fusion focuses on the discovery and development of oral covalent small molecules aimed at improving the lives of patients with diabetes and obesity. Their core product offerings leverage the proprietary FUSION™ System, designed to create next-generation covalent-binding medicines. These therapies work by forming permanent bonds with target proteins, providing enhanced target selectivity and the potential for more durable therapeutic responses compared to conventional non-covalent drugs. The company is developing a pipeline of three novel covalent inhibitor programs currently in preclinical and clinical development.Biomea Fusion generates revenue through partnerships and collaborations associated with the development and commercialization of its therapeutic candidates. These transactions typically involve agreements with pharmaceutical companies, healthcare institutions, and research organizations, which may include milestone payments and royalties based on product performance.In April 2021, Biomea Fusion, Inc.00 mn in an IPO, selling 9 million shares at USD 17 per share on the Nasdaq Global Select Market. The company plans to explore new markets for its innovative therapies, with a focus on expanding its presence in North America and Europe by 2024.
Who invested in Biomea Fusion
9 investors across 1 round
See all investors in Biomea Fusion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 23, 2020
Amount
$56M
Investors
Questions about Biomea Fusion
Who invested in Biomea Fusion?
Biomea Fusion has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biomea Fusion raised?
Biomea Fusion has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Biomea Fusion last raise money?
Biomea Fusion's most recent round on record is a Series A, in Dec 2020.
What does Biomea Fusion do?
Founded in 2017 and headquartered in Redwood City, US, Biomea Fusion, Inc.
Where is Biomea Fusion headquartered?
Biomea Fusion is headquartered in Redwood City, US.
Which VCs invest in companies like Biomea Fusion?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Biomea Fusion's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Biomea Fusion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.